Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

por Rob, Daniel, Marek, Josef, Dostálová, Gabriela, Goláň, Lubor, Linhart, Aleš
Publicado 2016

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

por Rob, Daniel, Marek, Josef, Dostálová, Gabriela, Goláň, Lubor, Linhart, Aleš
Publicado 2017

Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey

por Marek, Josef, Lubanda, Jean-Claude, Cifkova, Renata, Kuchynka, Petr, Golan, Lubor, Nemcek, Eduard, Linhart, Ales
Publicado 2019

Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease

por Jirásková, Alena, Bortolussi, Giulia, Dostálová, Gabriela, Eremiášová, Lenka, Golaň, Lubor, Danzig, Vilém, Linhart, Aleš, Vítek, Libor
Publicado 2017

Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients

por Keslová-Veselíková, Jana, Hůlková, Helena, Dobrovolný, Robert, Asfaw, Befekadu, Poupětová, Helena, Berná, Linda, Sikora, Jakub, Goláň, Lubor, Ledvinová, Jana, Elleder, Milan
Publicado 2008

The coincidence of IgA nephropathy and Fabry disease

por Maixnerová, Dita, Tesař, Vladimír, Ryšavá, Romana, Reiterová, Jana, Poupětová, Helena, Dvořáková, Lenka, Goláň, Lubor, Neprašová, Michaela, Kidorová, Jana, Merta, Miroslav, Honsová, Eva
Publicado 2013

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado 2015